Nadezhda Kudryavtseva, who suffers from Bechterew's disease, has been self-funding her vital treatment for two years. However, after exhausting family savings, her attempt to obtain the drug through the state has faced bureaucratic and medical hurdles.

StoriesThe struggle for life-saving medicationSlides: 7
  1. The struggle for life-saving medication
  2. The situation: Nadezhda Kudryavtseva, a person with Group 1 visual disability, cannot afford therapy; Conflicting medical opinions prevent state drug provision; Lack of state support after exhausting family savings
  3. 1 000 000 som — spent on medication over two years
  4. 15 mg — daily drug dosage of Ranvek
  5. «Compared to a 2024 study, bone marrow edema in the sacroiliac joints is no longer visible.» — Nadezhda Kudryavtseva
  6. The risks: Without regular medication, there is a risk of irreversible vision loss; Financial ability to continue therapy was lost at the beginning of 2026
  7. What it means. The case highlights the bureaucratic hurdles and medical contradictions faced by people with chronic diseases in Kyrgyzstan.

Contradictions in diagnoses

After the woman sought assistance from state structures, she encountered inconsistencies in medical data. While some specialists confirm the previously established diagnosis of "ankylosing spondylitis," other doctors find insufficient grounds to confirm it.

According to the patient, taking the prescribed Ranvek at a dosage of 15 milligrams per day has had a positive effect on her condition. As evidence of its effectiveness, she cites MRI data: compared to a 2024 study, bone marrow edema in the sacroiliac joints is no longer visible.

Cost of treatment

1,000,000som spent on medication
2 yearsperiod of self-funded purchase
15 mgdaily drug dosage

At the beginning of 2026, the financial ability to continue therapy was lost. The situation is complicated by the fact that without regular medication, there is a risk of irreversible deterioration of vision.

Context

Bechterew's disease (ankylosing spondylitis) is a chronic condition affecting the spine and joints. Nadezhda Kudryavtseva was diagnosed in 2024 at the "Semya i Zdorovye" private medical center.